As we get ready for Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) earnings, we have an opportunity to take a quantitative approach to preparation. The company’s first numbers are slated to hit the wires after market close (confirmed) on May 16, 2017. Hence, it’s a good time to take a thorough look at the company’s historical behavior around earnings, as well as where current expectations stand for performance in the quarter.
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) Historical Stock Behavior Data for Earnings Reports
According to market and research data, the company’s average earnings surprise was -27.19 percent, when looking at the prior year. Let’s look at how these four reports worked out in detail.
The company put up an EPS number of -0.31 on March 01, 2017. That missed the consensus expectation of $-0.20, representing a Negative surprise of -57.60% That report showed a top line number of $0M, which compares to a consensus estimate of $0M. In reaction, the stock dropped -5.46% on the next day. A week later, the price change was -2.11%.
The company put up an EPS number of $-0.22 on November 09, 2016. That compared with a consensus expectation of $-0.20, representing a Negative surprise -8.91%. That report also showed a top line number of $0M, which compares to a consensus estimate of $0M put out by analysts ahead of the report. That spurred a move of 3.11% a day later. Seven days after that, the stock had posted a net move of 6.21%.
If we look back at August 08, 2016, we see a company able to log an EPS print of $-0.23. That missed the projected outlook of $-0.20, handing the market a Negative surprise of -16.16%. Sales came in at $0M, which countered expectations of $0M, leading to a net move in shares of 5.42% the following day, and 9.76% seven days out.
Finally, on May 09, 2016, we saw a Negative surprise of -26.09% when the company came to the table with an EPS of $-0.29, answering analysts at $-0.23 on the bottom line. The top line hit at $0M (versus $0M).
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP): What’s the Word on the Street?
This time around, Q1 is expected to offer up an EPS point of $-0.23, with a range of $-0.32-$-0.16.
Shares of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) printed a last close of $4.12, which pushes the total market value of the company to roughly $941.50M. Where is it headed from here? It’s impossible to say, but analysts currently have a consensus 12-month target out right now at $11.03.
Looking at recent action, we’ve seen shares declined -42.38% off trailing year highs, but advance overall 1 a ytd basis. The stock has been bouncing in a recent range defined by the $4.11-$4.23 levels, with transactions averaging about 2,902,082 shares per day. Over about the past week, the stock has moved nearly 0.24% higher, representing a total gain of 57.25% off its 52-week low.
Finally, the summary performance stats on reporting suggest that there is roughly a 66 percent chance that the stock down in reaction to its next quarterly data peek. If we dig a bit deeper, we can see that shares of the stock saw gains about down 8 out of 12 quarters on recent record. As far as the actual results, the company has “beaten the number” at a rate of roughly 33% over its past 12 reports. On the other hand, the company swung and missed 7 times, with 1 instances of inline data. At present, the company’s stock price per share has shifted about -25.7% percent since the last time it turned in a report card, when it was printing orders around $5.68/share.